SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015774
Filing Date
2020-11-05
Accepted
2020-11-05 16:30:48
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20200930.htm   iXBRL 10-Q 1682128
2 RULE 13A-14(A) CERTIFICATION exhibit311ceoq32020.htm EX-31.1 10053
3 RULE 13A-14(A) CERTIFICATION exhibit312cfoq32020.htm EX-31.2 10025
4 SECTION 1350 CERTIFICATIONS exhibit321ceocfoq32020.htm EX-32.1 7072
  Complete submission text file 0001628280-20-015774.txt   6702710

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20200930.xsd EX-101.SCH 38181
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20200930_cal.xml EX-101.CAL 65977
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20200930_def.xml EX-101.DEF 222088
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20200930_lab.xml EX-101.LAB 533938
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20200930_pre.xml EX-101.PRE 370551
10 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20200930_htm.xml XML 1031182
Mailing Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 201290967
SIC: 2834 Pharmaceutical Preparations